{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:14:36Z","timestamp":1788387276103,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001066"],"award-info":[{"award-number":["82001066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["22JR5RA904"],"award-info":[{"award-number":["22JR5RA904"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jcms.2026.104566","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:39:23Z","timestamp":1776076763000},"page":"104566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Precision therapy for BRAF V600E\u2013mutated ameloblastoma: Systematic review insights"],"prefix":"10.1016","volume":"54","author":[{"given":"Yuqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Momen-Heravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfu","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-2086","authenticated-orcid":false,"given":"Qiwen","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2026.104566_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105854","article-title":"Managing stage 4 ameloblastoma with dual BRAF\/MEK inhibition: a case report with 8-year clinical follow-up","volume":"128","author":"Abramson","year":"2022","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/jop.13506","article-title":"Comparison of diagnostic methods for detection of BRAFV600E mutation in ameloblastoma","volume":"53","author":"Anbinselvam","year":"2024","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31557\/apjcb.2022.7.1.29-35","article-title":"Frequency of expression of BRAF V600E and EGFR in ameloblastoma","volume":"7","author":"Bashir","year":"2022","journal-title":"Asian Pac. J. Cancer Biol."},{"issue":"8","key":"10.1016\/j.jcms.2026.104566_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jclinpath-2021-207527","article-title":"Ameloblastoma cooperative group. Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres","volume":"75","author":"Bonacina","year":"2022","journal-title":"J Clin Pathol."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13256-019-2140-6","article-title":"Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report","volume":"13","author":"Broudic-Guibert","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jcms.2026.104566_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P7-13","article-title":"The phosphoinositide 3-kinase pathway and therapy resistance in cancer","volume":"7","author":"Brown","year":"2015","journal-title":"F1000Prime Rep."},{"issue":"21","key":"10.1016\/j.jcms.2026.104566_bib7","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1158\/1078-0432.CCR-14-1069","article-title":"Activating FGFR2-RAS-BRAF mutations in ameloblastoma","volume":"20","author":"Brown","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcms.2026.104566_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fonc.2019.01204","article-title":"Enabling precision medicine for rare head and neck tumors: the example of BRAF\/MEK targeting in patients with metastatic ameloblastoma","volume":"9","author":"Brunet","year":"2019","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.jcms.2026.104566_bib9","article-title":"Efficiency of B-RAF\/MEK-inhibitors in B-RAF mutated ameloblastoma: case report and review of literature","volume":"9","author":"B\u00fcettner","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jop.13399","article-title":"Factors affecting the accuracy of anti-braf v600e immunohistochemistry results in ameloblastomas","volume":"52","author":"Chang","year":"2023","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jcms.2026.104566_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41419-020-2560-7","article-title":"LGR5+ epithelial tumor stem-like cells generate a 3D-organoid model for ameloblastoma","volume":"11","author":"Chang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib12","article-title":"Clinicopathological relevance of BRAF and SMO mutations in Chinese patients with ameloblastoma","volume":"16","author":"Chen","year":"2023","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.jcms.2026.104566_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.oooo.2024.08.001","article-title":"Differences in BRAF V600E mutation between the epithelium and mesenchyme in classic ameloblastoma","volume":"138","author":"Chen","year":"2024","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00223-023-01177-x","article-title":"Resolution of PTHrP-Mediated hypercalcemia following treatment with dual BRAF\/MEK inhibition for BRAFV600E-Positive metastatic ameloblastoma","volume":"114","author":"Corbett","year":"2024","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PAI.0000000000000904","article-title":"Comparison of immunohistochemistry and DNA sequencing for braf v600e mutation detection in mandibular ameloblastomas","volume":"29","author":"da Silva Marcelino","year":"2021","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib16","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.4317\/medoral.23519","article-title":"High frequency of braf v600e mutation in Iranian population ameloblastomas","volume":"25","author":"Derakhshan","year":"2020","journal-title":"Med. OralPatol. Oral Cir. Bucal."},{"issue":"7","key":"10.1016\/j.jcms.2026.104566_bib17","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1007\/s13277-015-3238-0","article-title":"Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours","volume":"36","author":"Diniz","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.jcms.2026.104566_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00784-018-2494-y","article-title":"Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas","volume":"23","author":"do Canto","year":"2019","journal-title":"Clin. Oral Investig."},{"issue":"6","key":"10.1016\/j.jcms.2026.104566_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12032-023-01993-z","article-title":"BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature","volume":"40","author":"Ebeling","year":"2023","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib21","doi-asserted-by":"crossref","first-page":"djw190","DOI":"10.1093\/jnci\/djw190","article-title":"Durable treatment of ameloblastoma with single agent BRAFi re: clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"109","author":"Faden","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1186\/s12885-018-4802-y","article-title":"Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation","volume":"18","author":"Fernandes","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jcms.2026.104566_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/his.13095","article-title":"BRAF-V600E expression correlates with ameloblastoma aggressiveness","volume":"70","author":"Fregnani","year":"2017","journal-title":"Histopathology."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00428-018-2305-5","article-title":"The landscape of genetic alterations in ameloblastomas relates to clinical features","volume":"472","author":"G\u00fcltekin","year":"2018","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.jcms.2026.104566_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/ijpm.ijpm_398_21","article-title":"Detection and evaluation of the presence of the BRAF V600E mutation in ameloblastomas in an Indian population","volume":"66","author":"Goes","year":"2023","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jnci\/djad232","article-title":"Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach","volume":"116","author":"Grynberg","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0022034518798810","article-title":"The mutational profile of unicystic ameloblastoma","volume":"98","author":"Heikinheimo","year":"2019","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/odi.13031","article-title":"Global incidence and profile of ameloblastoma: a systematic review and meta-analysis","volume":"26","author":"Hendra","year":"2020","journal-title":"Oral Dis."},{"issue":"12","key":"10.1016\/j.jcms.2026.104566_bib29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/term.3254","article-title":"Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration","volume":"15","author":"Hirschhorn","year":"2021","journal-title":"J. Tissue Eng. Regen. Med."},{"issue":"3","key":"10.1016\/j.jcms.2026.104566_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.oooo.2025.03.006","article-title":"Plexiform ameloblastoma: a potential diagnostic challenge","volume":"140","author":"Huang","year":"2025","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"2","key":"10.1016\/j.jcms.2026.104566_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijom.2023.06.001","article-title":"Utility of BRAF V600E immunohistochemistry in the diagnosis of mandibular ameloblastomas","volume":"53","author":"Ji","year":"2024","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jnci\/dju378","article-title":"Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"107","author":"Kaye","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/odi.13072","article-title":"BRAF V600E expression in ameloblastomas-A 36-patient cohort from helsinki university hospital","volume":"25","author":"Kelppe","year":"2019","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/10668969211064203","article-title":"Genetic study of BRAF V600E and SMO L412F mutations in Japanese patients with ameloblastoma","volume":"30","author":"Kokubun","year":"2022","journal-title":"Int. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.jcms.2026.104566_bib36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijom.2021.12.011","article-title":"Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma","volume":"51","author":"Kunmongkolwut","year":"2022","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib38","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/j.oooo.2020.06.002","article-title":"Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas","volume":"132","author":"Lapthanasupkul","year":"2020","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000537707","article-title":"Maxillary ameloblastoma with local recurrence, orbital invasion, and systemic metastases: a case report and review of the literature","volume":"15","author":"Linaburg","year":"2024","journal-title":"Case Rep. Ophthalmol."},{"issue":"10","key":"10.1016\/j.jcms.2026.104566_bib40","article-title":"The role of BRAF inhibitors in the management of ameloblastoma: a literature review","volume":"15","author":"Malakar","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12105-024-01621-w","article-title":"BRAF p.V600E mutational status does not correlate with biological behavior in conventional ameloblastomas: a disease-free survival analysis","volume":"18","author":"Martins-de-Barros","year":"2024","journal-title":"Head Neck Pathol."},{"issue":"11","key":"10.1016\/j.jcms.2026.104566_bib45","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-022-01105-8","article-title":"The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma","volume":"35","author":"Mendez","year":"2022","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.jcms.2026.104566_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid. Based Med."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib47","first-page":"e70","article-title":"Surgical management of ameloblastoma. Review of literature","volume":"11","author":"Neagu","year":"2019","journal-title":"J. Clin. Exp. Dent."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jop.12851","article-title":"High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: clinicopathological significance and correlation with epithelial-mesenchymal transition","volume":"48","author":"Oh","year":"2019","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jcms.2026.104566_bib49","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.jcms.2026.104566_bib50","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/cancers16122174","article-title":"Anti-MAPK targeted therapy for ameloblastoma: case report with a systematic review","volume":"16","author":"Raemy","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib51","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/odi.13644","article-title":"Ameloblastoma shows nuclear BAP1 immunoexpression, independently of the BRAF V600E status","volume":"27","author":"Santana","year":"2021","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/pin.12899","article-title":"An immunohistochemical and genetic study of BRAFV600E mutation in Japanese patients with ameloblastoma","volume":"70","author":"Seki-Soda","year":"2020","journal-title":"Pathol. Int."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.surge.2020.06.009","article-title":"Ameloblastoma: a succinct review of the classification, genetic understanding and novel molecular targeted therapies","volume":"19","author":"Shi","year":"2021","journal-title":"Surgeon"},{"issue":"3","key":"10.1016\/j.jcms.2026.104566_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/jomfp.JOMFP_174_17","article-title":"Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: an institutional study","volume":"22","author":"Shirsat","year":"2018","journal-title":"J. Oral Maxillofac. Pathol."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib55","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.4317\/medoral.26493","article-title":"Frequency of BRAF V600E immunoexpression in ameloblastomas: a multi-institutional analysis of 86 cases in Latin America and comprehensive review of the literature","volume":"29","author":"Silveira","year":"2024","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/PAS.0000000000002375","article-title":"Novel histologic features in ameloblastoma with NRAS Q61R mutation","volume":"49","author":"Stojanov","year":"2025","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.jcms.2026.104566_bib57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7181\/acfs.2025.0018","article-title":"Molecular-targeted therapy in ameloblastoma: a systematic review","volume":"26","author":"Sulistyani","year":"2025","journal-title":"Arch. Craniofac. Surg."},{"issue":"7","key":"10.1016\/j.jcms.2026.104566_bib59","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.2986","article-title":"Identification of recurrent SMO and BRAF mutations in ameloblastomas","volume":"46","author":"Sweeney","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib60","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.oooo.2015.12.016","article-title":"BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response","volume":"122","author":"Tan","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"1","key":"10.1016\/j.jcms.2026.104566_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41368-022-00170-8","article-title":"Identification of BRAF V600E mutation in odontogenic tumors by high-performance maldi-tof analysis","volume":"14","author":"Togni","year":"2022","journal-title":"Int. J. Oral Sci."},{"issue":"5","key":"10.1016\/j.jcms.2026.104566_bib62","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14740338.2013.813017","article-title":"Drug safety evaluation of vemurafenib in the treatment of melanoma","volume":"12","author":"Tsai","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jcms.2026.104566_bib63","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19137","article-title":"A multi-center cross-sectional investigation of BRAF V600E mutation in ameloblastoma","volume":"13","author":"Tun","year":"2025","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.jcms.2026.104566_bib64","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/PAS.0000000000002104","article-title":"Adenoid ameloblastoma shares clinicopathologic, immunohistochemical, and molecular features with dentinogenic ghost cell tumor: a comparative analysis","volume":"47","author":"Xue","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.jcms.2026.104566_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jop.12807","article-title":"Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: a review","volume":"48","author":"You","year":"2019","journal-title":"J. Oral Pathol. Med."},{"issue":"7","key":"10.1016\/j.jcms.2026.104566_bib66","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/odi.15286","article-title":"Mutational landscape of ameloblastoma: analysis of BRAF and other key mutations in chinese patients","volume":"31","author":"You","year":"2025","journal-title":"Oral Dis."},{"issue":"6","key":"10.1016\/j.jcms.2026.104566_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180224","article-title":"Genetic basis of calcifying cystic odontogenic tumors","volume":"12","author":"Yukimori","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jcms.2026.104566_bib68","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1111\/odi.14909","article-title":"BRAF V600E mutation mediates invasive and growth features in ameloblastoma","volume":"30","author":"Zhang","year":"2024","journal-title":"Oral Dis."}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101051822600123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101051822600123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:42:03Z","timestamp":1784734923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S101051822600123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S101051822600123X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2026.104566","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision therapy for BRAF V600E\u2013mutated ameloblastoma: Systematic review insights","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2026.104566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104566"}}